4631 per patient， P=0.017). 
Summary and Conclusions 
Results of the IMPROVE-CHF trial show that in a universal access publicly-funded health care system that mandates judicious resource allocation， the use of NT-proBNP testing in conjunction with clinical assessment improves the overall management of patients presenting to ED with suspected acute HF， through the facilitation of diagnosis， risk stratification and cost savings that is accompanied by an improvement in selected outcomes. 
References 
1. American Heart Association. Heart Disease and Stroke Statistics - 2006 Update. Dallas， Texas: American Heart Association; 2006. 3 A.D. 9-15-2006. 2. Haldeman GA， Croft JB， Giles WH， Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey， 1985 to 1995. Am Heart J 1999;137:352-360. 3. Lasser KE， Himmelstein DU， Woolhandler S. Access to care， health status， and health disparities in the United States and Canada: results of a cross-national population-based survey. Am J Public Health 2006;96:1300-1307. 4. Johansen H， Strauss B， Arnold JM， Moe G， Liu P. On the rise: The current and projected future burden of congestive heart failure hospitalization in Canada. Can J Cardiol 2003;19:430-435. 5. Jong P， Vowinckel E， Liu PP， Gong Y， Tu JV. Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med 2002;162:1689-1694. 6. Lee DS， Austin PC， Rouleau JL， Liu PP， Naimark D， Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003;290:2581-2587. 7. Tsuyuki RT， Shibata MC， Nilsson C， Hervas-Malo M. Contemporary burden of illness of congestive heart failure in Canada. Can J Cardiol 2003;19:436-438. 8. Johansen H， Strauss B， Arnold JM， Moe G， Liu P. On the rise: The current and projected future burden of congestive heart failure hospitalization in Canada. Can J Cardiol 2003;19:430-435. 9. Tsuyuki RT， Shibata MC， Nilsson C， Hervas-Malo M. Contemporary burden of illness of congestive heart failure in Canada. Can J Cardiol 2003;19:436-438. 10. Harrison A， Morrison LK， Krishnaswamy P， Kazanegra R， Clopton P， Dao Q， Hlavin P， Maisel AS. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 2002;39:131-138. 11. Januzzi JL， Jr.， Camargo CA， Anwaruddin S， Baggish AL， Chen AA， Krauser DG， Tung R， Cameron R， Nagurney JT， Chae CU， Lloyd-Jones DM， Brown DF， Foran-Melanson S， Sluss PM， Lee-Lewandrowski E， Lewandrowski KB. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005;95:948-954. 12. Maisel AS， Krishnaswamy P， Nowak RM， McCord J， Hollander JE， Duc P， Omland T， Storrow AB， Abraham WT， Wu AH， Clopton P， Steg PG， Westheim A， Knudsen CW， Perez A， Kazanegra R， Herrmann HC， McCullough PA. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-167. 13. McCullough PA， Nowak RM， McCord J， Hollander JE， Herrmann HC， Steg PG， Duc P， Westheim A， Omland T， Knudsen CW， Storrow AB， Abraham WT， Lamba S， Wu AH， Perez A， Clopton P， Krishnaswamy P， Kazanegra R， Maisel AS. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002;106:416-422. 14. Moe GW. BNP in the Diagnosis and Risk Stratification of Heart Failure. Heart Fail Monit 2005;4:116-122. 15. Bayes-Genis A， Santalo-Bel M， Zapico-Muniz E， Lopez L， Cotes C， Bellido J， Leta R， Casan P， Ordonez-Llanos J. N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail 2004;6:301-308. 16. Lainchbury JG， Campbell E， Frampton CM， Yandle TG， Nicholls MG， Richards AM. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 2003;42:728-735. 17. Bayes-Genis A， Santalo-Bel M， Zapico-Muniz E， Lopez L， Cotes C， Bellido J， Leta R， Casan P， Ordonez-Llanos J. N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricul